Serum β₂-Microglobulin and Prognosis of Patients with Renal Cell Carcinoma

References

• Berggård I., Beam A. G. Isolation and properties of a low molecular weight β2-globulin occurring in human biological fluids. J Biol Chem 1968; 243: 4095–103
   PubMed Web of Science ®Google Scholar
• Grey H. M., Kubo R. T., Colon S. M., et al. The small subunit of HL-A antigens is β2-microglobulin. J Exp Med 1973; 138: 1608–12
   PubMed Web of Science ®Google Scholar
• Michalski J. P., Daniels T. E., Talal N., Grey H. M. Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med 1975; 293: 1228–31
   PubMed Web of Science ®Google Scholar
• Schardijn G. H. C., Statius Van Eps L. W. β2-Microglobulin: Its significance in the evaluation of renal function. Kidney Int 1987; 32: 635–41
   PubMed Web of Science ®Google Scholar
• Shuster J., Gold P., Poulik M. D. β2-Microglobulin levels in cancerous and other disease states. Clin Chim Acta 1976; 67: 307–13
   PubMed Web of Science ®Google Scholar
• Teasdale C., Mander A. M., Fifield R., Keyser J. W., Newcombe R. G., Hughes L. E. Serum β2-Microglobulin in controls and cancer patients. Clin Chim Acta 1977; 78: 135–43
   PubMed Web of Science ®Google Scholar
• Adami H. O., Hällgren R., Lundqvist G. Serum β2-microglobulin in women with breast cancer and in age-matched non-hospitalized controls. Clin Chim Acta 1979; 93: 43–9
   PubMedGoogle Scholar
• Bataille R., Durie B. G. M., Grenier J., Sany J. Prognostic factors and staging in multiple myeloma: a reappraisal. J Clin Oncol 1986; 4: 80–7
   PubMed Web of Science ®Google Scholar
• Johnson P. W. M., Whelan J., Longhurst S., et al. β2-Microglobulin: A prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. Br J Cancer 1993; 67: 792–7
   PubMed Web of Science ®Google Scholar
• Thrasher J. B., Paulson D. F. Prognostic factors in renal cancer. Urol Clin North Am 1993; 20: 247–62
   PubMed Web of Science ®Google Scholar
• Ljungberg B., Stenling R., Roos G. Prognostic value of deoxyribonucleic acid content in metastatic renal cell carcinoma. J Urol 1986; 136: 801–4
   PubMed Web of Science ®Google Scholar
• Rasmuson T., Grankvist K., Ljungberg B. Serum γ-enolase and prognosis of patients with renal cell carcinoma. Cancer 1993; 72: 1324–8
   PubMedGoogle Scholar
• Selli C., Cozzolino F., Carini M., Lenzi R., Vercelli D. Serum beta 2 microglobulin levels in patients with renal cell carcinoma. Urol Res 1984; 12: 261–3
   PubMedGoogle Scholar
• Popelier G., Sion H. Présence de la β2-microglobuline dans les tissus de reins normaux et carcinomateux. Pathol Biol 1978; 26: 367–9
   PubMedGoogle Scholar
• Levin I., Kuperman O., Goldstein J., et al. Cellular B-2 microglobulin expression as a prognostic indicator in renal cell carcinoma. Acta Oncol 1991; 30: 941–5
   PubMed Web of Science ®Google Scholar
• Robson C. J., Churchill B. M., Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297–301
   PubMed Web of Science ®Google Scholar
• Skinner D. G., Colvin R. B., Vermillion C. D., Pfister R. C., Leadbetter W. F. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971; 28: 1165–77
   PubMed Web of Science ®Google Scholar
• Claes G. Concerning the relationship between the morphology and the symptomatology of hypernephroma. Urol Int 1963; 15: 265–79
   PubMedGoogle Scholar
• Richards B., Robinson M. R. G., Pidcock N. B., Cooper E. H. Serum protein profiles in carcinoma of the kidney. Eur Urol 1982; 8: 32–6
   PubMed Web of Science ®Google Scholar
• Nilsson K., Evrin P-E, Welsh K. I. Production of β2-microglobulin by norma] and malignant human cell lines and peripheral lymphocytes. Transplant Rev 1974; 21: 53–84
   PubMed Web of Science ®Google Scholar
• Heinemann D., Smith P. J. B., Symes M. O. Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas. Br J Cancer 1987; 56: 433–7
   PubMed Web of Science ®Google Scholar
• Moss A. R., Bacchetti P., Osmond D., et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988; 296: 745–50
   PubMed Web of Science ®Google Scholar
• Strohmeyer T., Ackermann R. Classic and modem prognostic indicators in renal cell carcinoma. Review of the literature. Urol Int 1991; 47: 203–12
   PubMedGoogle Scholar